Teva Strikes Deal With Pfizer To Sell Generic Celebrex
The U.S. subsidiary of Teva Pharmaceutical Industries Ltd. has struck a deal with Pfizer Inc. that will allow it to begin selling generic versions of the blockbuster arthritis drug Celebrex by...To view the full article, register now.
Already a subscriber? Click here to view full article